👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

U.S. needs more baby formula makers, Biden tells manufacturers

Published 06/01/2022, 05:07 AM
Updated 06/01/2022, 05:42 PM
© Reuters. FILE PHOTO: U.S. President Joe Biden speaks during the 154th National Memorial Day Wreath-Laying and Observance ceremony to honor America's fallen, at Arlington National Cemetery in Arlington, U.S., May 30, 2022. REUTERS/Joshua Roberts
NESN
-
TGT
-
ABT
-
PRGO
-

By Trevor Hunnicutt and Jarrett Renshaw

(Reuters) -U.S. President Joe Biden met with major infant formula manufacturers on Wednesday, and suggested their ranks should grow, as his administration presses ahead with efforts to boost imported supplies to help ease a nationwide shortage."We need more new entrants in the infant formula market," Biden said during a virtual meeting with executives from ByHeart, Bubs Australia, Reckitt Benckiser Group, Perrigo Company (NYSE:PRGO) and Nestle SA (SIX:NESN)'s Gerber.

Multiple global suppliers are seeking U.S. approval to ship critical baby formula as Biden's administration accelerates what it has dubbed "Operation Fly Formula" to help fill store shelves and calm frustrated parents.

The approximately $4 billion annual sales U.S. baby formula market has historically been dominated by domestic producers, with imports limited and subject to high tariffs.

But U.S. parents have struggled to find baby formula in recent months after a February recall of some formulas by one of the nation's main manufacturers, Abbott Laboratories (NYSE:ABT), coupled with pandemic-related supply chain issues.

The latest administration effort to solve the problem includes an announcement on Wednesday that United Airlines has agreed to transport U.K.-made Kendamil formula free of charge from Heathrow Airport in London to multiple airports across the United States over a three-week period.

This first shipment, which includes Kendamil Classic and Kendamil Organic formula, will be available at Target (NYSE:TGT) stores across the country in the coming weeks.

The administration also secured two flights totaling 380,000 pounds of baby formula from Bubs Australia that will be delivered to California and Pennsylvania on June 9 and June 11, respectively.

Biden said on Wednesday he only learned of the severity of the U.S. baby formula shortage in early April. The White House said it had been working around the clock since February to address the problem.

U.S. lawmakers have criticized the Food and Drug Administration (FDA) for not acting promptly to address the problems that caused the recall at Abbott's Michigan plant, which is set to reopen June 4.

The Biden administration has relaxed its import policy and invoked the Defense Production Act to help increase available U.S. supplies, which is still expected to take weeks. It has also said it could use federal resources to help transport supplies to retailers.

Two million cans of formula have been sent from the U.K., and Australian manufacturers are also preparing to send in more product.

Thorben Nilewski of Organic Family GmbH, which makes the popular Holle infant formulas, said in an email that the German company applied for the FDA’s temporary approval but has not yet received any feedback.

© Reuters. U.S. President Joe Biden holds a meeting with White House officials and baby formula manufacturers, as part of the U.S. response to the ongoing baby formula shortage, in an auditorium on the White House campus in Washington, U.S. June 1, 2022. REUTERS/Jonathan Ernst

Many U.S. parents rely on baby formula. Fewer than half the babies born in the United States were exclusively breast-fed through their first three months, according to the Centers for Disease Control and Prevention's 2020 Breastfeeding Report Card.

The agency has said the company, which has the largest U.S. market share for infant formula, did not have a contingency plan to produce its specialty formulas that serve as the only source of nutrition for thousands of babies with metabolic disorders.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.